13
Views
86
CrossRef citations to date
0
Altmetric
Original Article

Excretion of Noradrenaline in Urine in Hypertension

, &
Pages 54-59 | Received 29 Oct 1953, Published online: 28 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Guido Grassi & Luciano F. Drager. (2024) Sympathetic overactivity, hypertension and cardiovascular disease: state of the art. Current Medical Research and Opinion 40:sup1, pages 5-13.
Read now
Fadl Elmula M. Fadl Elmula, Yu Jin, Wen-Yi Yang, Lutgarde Thijs, Yi-Chao Lu, Anne C. Larstorp, Alexandre Persu, Marc Sapoval, Ján Rosa, Petr Widimský, Lotte Jacobs, Jean Renkin, Ondřej Petrák, Gilles Chatellier, Kazuyuki Shimada, Jiři Widimský, Kazuomi Kario, Michel Azizi, Sverre E. Kjeldsen & Jan A. Staessen. (2015) Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Blood Pressure 24:5, pages 263-274.
Read now
Sverre E. Kjeldsen, Fadl E. M. Fadl Elmula, Alexandre Persu, Yu Jin & Jan A. Staessen. (2014) Renal sympathetic denervation in the aftermath of Symplicity HTN-3. Blood Pressure 23:5, pages 256-261.
Read now
John A D’Elia & Larry A Weinrauch. (2013) The autonomic nervous system and renal physiology. International Journal of Nephrology and Renovascular Disease 6, pages 149-160.
Read now
Gavin W. Lambert, Claudia Ferrier, David M. Kaye, Victor Kalff, Michael J. Kelly, Helen S. Cox, Andrea G. Turner, Garry L. Jennings & Murray D. Esler. (1994) Monoaminergic Neuronal Activity in Subcortical Brain Regions in Essential Hypertension. Blood Pressure 3:1-2, pages 55-66.
Read now
M. Esler, G. Jennings, P. Korner, P. Blombery, F. Burke, I. Willett & P. Leonard. (1984) Total, and Organ-Specific, Noradrenaline Plasma Kinetics in Essential Hypertension. Clinical and Experimental Hypertension. Part A: Theory and Practice 6:1-2, pages 507-521.
Read now
S. Gitlow, S. Dziedzic, L. Dziedzic & I. Roubein. (1981) Metabolism of D, L-3H-Norepinephrine in Essential Hypertension. Clinical and Experimental Hypertension 3:5, pages 897-918.
Read now

Articles from other publishers (79)

Guido Grassi, Fosca Quarti-Trevano & Murray D. Esler. (2019) Sympathetic activation in congestive heart failure: an updated overview. Heart Failure Reviews 26:1, pages 173-182.
Crossref
Qingyu Kong, Xiaofei Yang, Zhifeng Cai, Yanyan Pan, Minmin Wang, Mengmeng Liu & Cuifen Zhao. (2019) Twenty-four-hour urine NE level as a predictor of the therapeutic response to metoprolol in children with recurrent vasovagal syncope. Irish Journal of Medical Science (1971 -) 188:4, pages 1279-1287.
Crossref
Ahmad Al-Fakhouri, Nephertiti Efeovbokhan, Rami Nakhla & Rami N. Khouzam. (2016) Renal denervation in the treatment of resistant hypertension: Dead, alive or surviving?. Revista Portuguesa de Cardiologia (English Edition) 35:10, pages 531-538.
Crossref
Ahmad Al-Fakhouri, Nephertiti Efeovbokhan, Rami Nakhla & Rami N. Khouzam. (2016) Renal denervation in the treatment of resistant hypertension: Dead, alive or surviving?. Revista Portuguesa de Cardiologia 35:10, pages 531-538.
Crossref
Manuel de Sousa Almeida, Pedro de Ara?jo Gon?alves, Eduardo Infante de Oliveira & Henrique Cyrne de Carvalho. (2015) Renal denervation for resistant hypertension. Revista Portuguesa de Cardiologia (English Edition) 34:2, pages 125-135.
Crossref
Manuel de Sousa Almeida, Pedro de Ara?jo Gon?alves, Eduardo Infante de Oliveira & Henrique Cyrne de Carvalho. (2015) Renal denervation for resistant hypertension. Revista Portuguesa de Cardiologia 34:2, pages 125-135.
Crossref
Sverre E. Kjeldsen, Fadl Elmula M. Fadl Elmula, Ingrid Os, Alexandre Persu, Yu Jin & Jan A. Staessen. (2015) Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in patients with resistant hypertension to improve patients' adherence. European Heart Journal - Cardiovascular Pharmacotherapy 1:1, pages 48-56.
Crossref
George Bayliss, Larry A. Weinrauch & John A. D’Elia. (2014) Resistant Hypertension in Diabetes Mellitus. Current Diabetes Reports 14:8.
Crossref
Murray Esler. (2014) Sympathetic Nervous System Moves Toward Center Stage in Cardiovascular Medicine. Hypertension 63:3.
Crossref
Murray Esler. (2011) The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Experimental Physiology 96:7, pages 611-622.
Crossref
Gavin Lambert & Guido Grassi. (2010) Indices of sympathetic activity and the paradox of chromogranin A. Journal of Hypertension 28:4, pages 676-678.
Crossref
Murray Esler. (2010) The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. Journal of Applied Physiology 108:2, pages 227-237.
Crossref
P. Armario, R. Hern?ndez del Rey & M.C. Almendros Ribas. (2001) Papel del sistema nervioso simp?tico en la etiopatogenia de la hipertensi?n arterial. Hipertensi?n y Riesgo Vascular 18:7, pages 327-335.
Crossref
Murray D. Esler. (1998) Mental stress, panic disorder and the heart. Stress Medicine 14:4, pages 237-243.
Crossref
GAVIN W. LAMBERT, CLAUDIA FERRIER, DAVID M. KAYE, GARRY L. JENNINGS, VICTOR KALFF, MICHAEL J. KELLY, HELEN S. COX, ANDREA G. TURNER & MURRAY D. ESLER. (2006) Central Nervous System Norepinephrine Turnover in Essential Hypertension fn1 . Annals of the New York Academy of Sciences 763:1, pages 679-694.
Crossref
Murray David Esler. (1993) Catecholamines and essential hypertension. Baillière's Clinical Endocrinology and Metabolism 7:2, pages 415-438.
Crossref
L. Aldo Ferrara, Marcello Mancini, Giuseppina De Simone, Salvatore Turco, Ciro Iovine, Teodoro Marotta, Giovanni Mainenti & Mario Mancini. (1991) Responses of serum insulin and blood pressure to cold and handgrip in obese patients. International Journal of Cardiology 32:3, pages 353-359.
Crossref
M EslerG JenningsP KornerI WillettF DudleyG HaskingW AndersonG Lambert. (1988) Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover.. Hypertension 11:1, pages 3-20.
Crossref
Murray Esler, Ian Willett, Paul Leonard, Greg Hasking, Jennifer Johns, Peter Little & Garry Jennings. (1984) Plasma noradrenaline kinetics in humans. Journal of the Autonomic Nervous System 11:2, pages 125-144.
Crossref
M. Esler, G. Jennings, P. Korner, P. Blombery, N. Sacharias & P. Leonard. (1984) Measurement of total and organ-specific norepinephrine kinetics in humans. American Journal of Physiology-Endocrinology and Metabolism 247:1, pages E21-E28.
Crossref
Takashi Mandai, Toshio Ogihara, Takeshi Hata, Yoshiaki Okada, Saburo Ogasahara, Hiroshi Mikami, Mitsuaki Nakamaru & Yuichi Kumahara. (2015) Urinary Catecholamine Response to Glucagon in Young and Elderly Patients with Essential Hypertension†. Journal of the American Geriatrics Society 28:10, pages 462-465.
Crossref
D P Henry, F C Luft, M H Weinberger, N S Fineberg & C E Grim. (1980) Norepinephrine in urine and plasma following provocative maneuvers in normal and hypertensive subjects.. Hypertension 2:1, pages 20-28.
Crossref
NICOLAS D. VLACHAKIS. (2013) Hemodynamic Effect of Propranolol Therapy in Relationship to Renin Status and Plasma Catecholamines in Primary Hypertension. The Journal of Clinical Pharmacology 20:1, pages 20-29.
Crossref
NICOLAS D. VLACHAKIS. (2013) Blood Pressure Response to Norepinephrine Infusion in Relationship to Plasma Catecholamines and Renin Activity in Man. The Journal of Clinical Pharmacology 19:10, pages 654-661.
Crossref
Milton Mendlowitz & Nicolas D. Vlachakis. (1976) The catecholamines in essential hypertension. American Heart Journal 91:3, pages 378-382.
Crossref
O. KuchelJ.L. CucheP. HametG. TolisF.H. MesserliA. BarbeauR. BoucherJ. Genest. (2016) Labile (Borderline) Hypertension—New Aspects of a Common Disorder. Angiology 26:8, pages 619-631.
Crossref
Charles A. ChidseyIIIIII & Thomas B. Gottlieb. (1974) The pharmacologic basis of antihypertensive therapy: The role of vasodilator drugs. Progress in Cardiovascular Diseases 17:2, pages 99-113.
Crossref
Robert Hoeldtke. (1974) Catecholamine metabolism in health and disease. Metabolism 23:7, pages 663-686.
Crossref
J. F. BergmannJulius St. Hansson. 1974. Achtzigster Kongress. Achtzigster Kongress 49 58 .
M. D. ESLER & P. J. NESTEL. (1973) ESSENTIAL HYPERTENSION WITH SYMPTOMS OF HYPERKINETIC CIRCULATION. Medical Journal of Australia 2:6, pages 253-257.
Crossref
M. D. Esler & P. J. Nestel. (1973) High Catecholamine Essential Hypertension: Clinical and Physiological Characteristics. Australian and New Zealand Journal of Medicine 3:2, pages 117-123.
Crossref
. (2009) References. Acta Medica Scandinavica 193:S550, pages 38-40.
Crossref
Harriet P. Dustan, Robert C. Tarazi & Emmanuel L Bravo. (1972) Physiologic characteristics of hypertension. The American Journal of Medicine 52:5, pages 610-622.
Crossref
P.J. Nestel. (1969) BLOOD-PRESSURE AND CATECHOLAMINE EXCRETION AFTER MENTAL STRESS IN LABILE HYPERTENSION. The Lancet 293:7597, pages 692-694.
Crossref
P. J. NESTEL & A. E. DOYLE. (2017) THE EXCRETION OF FREE NORADRENALINE AND ADRENALINE BY HEALTHY YOUNG SUBJECTS AND BY PATIENTS WITH ESSENTIAL HYPERTENSION. Australasian Annals of Medicine 17:4, pages 295-299.
Crossref
A.W. Stott & R. Robinson. (1967) Urinary normetadrenaline excretion in essential hypertension. Clinica Chimica Acta 16:2, pages 249-252.
Crossref
JACQUES DE CHAMPLAIN, LAWRENCE R. KRAKOFF & JULIUS AXELROD. (1967) Catecholamine Metabolism in Experimental Hypertension in the Rat. Circulation Research 20:1, pages 136-145.
Crossref
Alexander SturmJr.Jr.. (1966) Hypertonie und erhöhte Katecholaminausscheidung. Archiv für Kreislaufforschung 51:1-2, pages 103-160.
Crossref
R. Clotten & J. Michaelis. (1966) Untersuchungen zur Ausscheidung der Katecholamine und ihrer Abbauprodukte bei Hypertonikern und beim Phäochromocytom. Klinische Wochenschrift 44:20, pages 1161-1171.
Crossref
E. Schmid. (1966) Untersuchungen über Physiologie und Pathophysiologie des sympathikoadrenalen Systems durch Bestimmung der Vanillin-Mandelsäure-Ausscheidung im Harn mit dünnschichtehromatographischer Technik. Archiv für Kreislaufforschung 49:1-2, pages 83-116.
Crossref
M. I. Linna, A. Aho, A. Pekkarinen & M. L. Salmivalli. (2009) The Effect of Prolonged Treatment with Noradrenaline in Oil, along with Sodium Chloride and Deoxycortone, on the Blood Pressure of Rats. Acta Pharmacologica et Toxicologica 22:4, pages 319-330.
Crossref
Al. Ciplea, G. Bubuianu & Elena Gaˇlaˇs¸anu. (1964) Study on cerebrospinal fluid catecholamines in hypertensive disease. International Journal of Neuropharmacology 3:6, pages 583-592.
Crossref
Shannon Brunjes. (1964) Catechol Amine Metabolism in Essential Hypertension. New England Journal of Medicine 271:3, pages 120-124.
Crossref
Pedro A. Serrano, Guillermo Figueroa, Manuel Z Torres & Adela Ramírez Del Angel. (1964) Adrenaline, Noradrenaline and Dopamine excretion in patients with essential hypertension. The American Journal of Cardiology 13:4, pages 484-488.
Crossref
Milton Mendlowitz, Stanley E. Gitlow, Robert L. Wolf & Nosrat E. Naftchi. (1964) On the integration of factors in essential hypertension. American Heart Journal 67:3, pages 397-409.
Crossref
T. Symington. (2008) THE PATHOLOGY OF ADRENAL HYPERACTIVITY1. British Journal of Urology 35:4, pages 329-341.
Crossref
Alice E. Fruehan & Thomas F. Frawley. (2005) Adrenal medullary function in the connective tissue disorders. Arthritis & Rheumatism 6:6, pages 698-710.
Crossref
OLLI CASTRÉN. (2009) URINARY EXCRETION OF NORADRENALINE AND ADRENALINE IN LATE NORMAL AND TOXEMIC PREGNANCY. Acta Pharmacologica et Toxicologica 20:S2, pages 1-98.
Crossref
James Conway. (1963) Current concepts concerning the etiology of essential hypertension. American Heart Journal 66:3, pages 409-413.
Crossref
W. De Potter, Z.M. Bacq, G. Criel, A.F. De Schaepdryver & J. Renson. (1963) O- and N-demethylation of metanephrine-7-3H in vivo. Biochemical Pharmacology 12:7, pages 661-667.
Crossref
Grace M. Roth. (1962) The role of the catecholamines in hypertension. The American Journal of Cardiology 9:5, pages 724-730.
Crossref
H. G. Knauff, G. Fruhmann & G. Verbeek. (1962) Die Ausscheidung von Adrenalin und Noradrenalin bei Asthma bronchiale und bei Lungenemphysem. Klinische Wochenschrift 40:8, pages 411-415.
Crossref
H. J. Kuschke, A. Igata & B. Ferneding. (1962) Zur Frage der Monoaminooxydase-Aktivität bei essentieller Hypertonie. Klinische Wochenschrift 40:6, pages 322-322.
Crossref
H. G. Knauff & G. Verbeek. (1962) Fluorimetrische Bestimmung von Adrenalin und Noradrenalin im Harn. Ergebnisse bei Gesunden und bei Patienten mit Hypertonus. Klinische Wochenschrift 40:1, pages 18-23.
Crossref
J Kelleher & G Walters. (1961) CHEMICAL TESTS FOR PHÆOCHROMOCYTOMA. The Lancet 278:7215, pages 1312-1313.
Crossref
TimothyS. Harrison. (1961) ADRENAL MEDULLARY SECRETION IN HYPERTHYROIDISM. The Lancet 278:7215, pages 1311-1312.
Crossref
H. J. Kuschke. (1961) Untersuchungen über den Erregungszustand des sympathischen Nervensystems und des Nebennierenmarkes bei kardiovaskulären Erkrankungen. Archiv für Kreislaufforschung 36:1-2, pages 104-148.
Crossref
ALBERT SJOERDSMA. (1961) Relationships Between Alterations in Amine Metabolism and Blood Pressure. Circulation Research 9:3, pages 734-745.
Crossref
McC. Goodall & Morton Bogdonoff. (1961) Essential hypertension with an elevated noradrenaline excretion. American Heart Journal 61:5, pages 640-645.
Crossref
R. Wien. 1961. 34 71 .
David M. Hume. (1960) Pheochromocytoma in the adult and in the child. The American Journal of Surgery 99:4, pages 458-496.
Crossref
E. Wollheim & J. Moeller. 1960. Hypertonie · Hypotonie. Hypertonie · Hypotonie 1 776 .
E. Wollheim & J. Moeller. 1960. Herz und Kreislauf. Herz und Kreislauf 1 776 .
Grace M. Roth, Eunice V. Flock, Jesse L. Bollman & Walter F. Kvale. (2016) Evaluation of the Pharmacologic and Chemical Tests as an Aid To Diagnosis of Pheochromocytoma a b. Angiology 10:6, pages 426-430.
Crossref
Wilhelm Raab. (1959) Transmembrane gationic gradient and blood pressure regulation. The American Journal of Cardiology 4:6, pages 752-774.
Crossref
E. Hochuli. (1959) Adrenalin- und Noradrenainlbestimmungen im Blutplasma bei schweren Pr�eklampsien und essentiellen Hypertonien. Klinische Wochenschrift 37:22, pages 1196-1196.
Crossref
ROGER B. HICKLERJAMES T. HAMLINIIIIIIROE E. WELLSJR.JR.. (1959) Plasma Norepinephrine Response to Tilting in Essential Hypertension. Circulation 20:3, pages 422-426.
Crossref
Rolf Heinecker & Karl-Eberhard Zipf. (1959) Individuelle Unterschiede in der Reaktion von Kreislauf und Gasstoffwechsel auf dosierte Belastungen: Cold Pressor Test, Flickerlicht, L?rm, k?rperliche Arbeit. Archiv f?r Kreislaufforschung 30:1-2, pages 1-103.
Crossref
Adrian M. Ostfeld. (2016) Some Aspects of Cardiovascular Regulation in Man*†. Angiology 10:1, pages 34-42.
Crossref
Andrew Viranyi, A. Szendei & J. Komáromy. (1958) Pheochromocytoma. The American Journal of Cardiology 2:4, pages 423-429.
Crossref
Emanuel Goldberger. (1958) The pathogenesis of essential hypertension. The American Journal of Cardiology 1:2, pages 154-175.
Crossref
. (2009) REFERENCES. Acta Medica Scandinavica 161:s336, pages 51-52.
Crossref
GEORGE E. WAKERLIN. (1957) Editorial. Circulation 15:1, pages 1-4.
Crossref
J.H. Gaddum & Margarethe Holzbauer. 1957. 151 203 .
E. Werle. 1957. Der Stoffwechsel. Der Stoffwechsel 1 202 .
Alexis LabhartA. Labhart, Chr. Hedinger & G. Töndury. 1957. Klinik der inneren Sekretion. Klinik der inneren Sekretion 403 415 .
J. M. B. BLOODWORTHJR.JR. & E. VON HAAM. (1956) The Tissue Catechol Amine Concentration of the Human Heart Determined by the Aluminum Hydroxide-Arsenomolybdic Acid Method. Circulation 13:4, pages 573-580.
Crossref
U. S. VON EULER. (2009) Catechol Amines in Hypertension. Acta Medica Scandinavica 154:S312, pages 78-81.
Crossref
R. Moulton & D.A. Willoughby. (1955) A SHORT LABORATORY SCREENING TEST FOR PH?OCHROMOCYTOMA. The Lancet 266:6879, pages 16-18.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.